2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow SB 743921: new trials by email Literature Review of SB 743921 trials Research Report on SB 743921
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of SB-743921 in Non-Hodgkin Lymphoma and Hodgkin Lymphoma SB-743921 - Non-Hodgkin's Lymphoma, Hodgkin's Disease | Phase 1 / Phase 2 | Completed | Cytokinetics | 68 | 2006-04-01 | 2020-01-13 |
| SB-743921 In Patients With Solid Tumors SB-743921 - Solid Tumor Cancer | Phase 1 | Completed | GlaxoSmithKline | 30 | 2004-04-01 | 2008-10-16 |
Hodgkin Disease (1) · Lymphoma, Non-Hodgkin (1)
Cytokinetics (1) · GlaxoSmithKline (1)
United States (2) · Russia (1)